Results 71 to 80 of about 508,363 (252)

Macro, Micro, and Nano-Inspired Bioactive Polymeric Biomaterials in Therapeutic, and Regenerative Orofacial Applications

open access: yesDrug Design, Development and Therapy, 2023
Gamal A Atia,1 Hany K Shalaby,2 Ali B Roomi,3,4 Mohamed M Ghobashy,5 Hager A Attia,6 Sara Z Mohamed,7 Ahmed Abdeen,8 Mohamed Abdo,9,10 Liana Fericean,11 Ioan Bănățean Dunea,11 Ahmed M Atwa,12 Tabinda Hasan,13 Wessam Mady,14 Afaf Abdelkader ...
Atia GA   +20 more
doaj  

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

Knowledge, Attitudes, and Practices of Antimicrobial Uses and Resistance Among Public University Students in Bangladesh

open access: yesInfection and Drug Resistance, 2021
Mahfuza Marzan,1 Dewan Zubaer Islam,1 Halyna Lugova,2 Ambigga Krishnapillai,3 Mainul Haque,4 Salequl Islam1 1Department of Microbiology, Jahangirnagar University, Savar, Dhaka, 1342, Bangladesh; 2The Unit of Community Medicine, Faculty of Medicine and ...
Marzan M   +5 more
doaj  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Comments on – Experiences of Obese Polish Patients When Interacting with Healthcare Professionals [Letter]

open access: yesPatient Preference and Adherence, 2020
Oluwaseun Ikotun, Esther Wan Ching Lee The University of Manchester, Faculty of Biology, Medicine and Health, Manchester, UKCorrespondence: Oluwaseun IkotunThe University of Manchester, Faculty of Biology, Medicine and Health, Manchester, UKEmail ...
Ikotun O, Lee EWC
doaj  

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

open access: yesMolecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh   +12 more
wiley   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Study Habits of Highly Effective Medical Students: A Medical Student’s Perspective [Letter]

open access: yesAdvances in Medical Education and Practice, 2021
Durray Nayab Ali The University of Manchester, Faculty of Biology, Medicine and Health, Manchester, UKCorrespondence: Durray Nayab Ali Email durray.ali@student.Manchester.ac.uk View the original paper by Prof. Dr.
Ali D
doaj  

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy